Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lane

Showing results (701-710 of 1,428) with videos related to

Pageof 143
Sort By:
The Biochemical Journal|June 10, 2010
The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophagesAmanda E Lane, Joanne T M Tan, Clare L Hawkins, et al.
Osteoarthritis and Cartilage|March 15, 2011
OARSI-FDA initiative: defining the disease state of osteoarthritisN E Lane, K Brandt, G Hawker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 1998
Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivoN E Lane, J M Thompson, D Haupt, et al.
The American Journal of Pathology|October 6, 2015
Sphingosine-1-phosphate receptor antagonism enhances proliferation and migration of engrafted neural progenitor cells in a model of viral-induced demyelinationCaroline A Blanc, Jonathan J Grist, Hugh Rosen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 20, 2016
Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention TrialW B Katzman, E Vittinghoff, D M Kado, et al.
The Journal of Clinical Investigation|October 28, 1998
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trialN E Lane, S Sanchez, G W Modin, et al.
Evolution; International Journal of Organic Evolution|May 26, 2017
Multilevel and sex-specific selection on competitive traits in North American red squirrelsDavid N Fisher, Stan Boutin, Ben Dantzer, et al.
Arthritis and Rheumatism|January 30, 2010
Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men studyR K Chaganti, N Parimi, P Cawthon, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 12, 2000
Identification and regional distribution of the dopamine D(1A) receptor in the gastrointestinal tractC J Vaughan, A M Aherne, E Lane, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 10, 2000
Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trialN E Lane, S Sanchez, G W Modin, et al.
Pageof 143

Showing results (701-710 of 1,428) with videos related to

Sort By:
Pageof 143
The Biochemical Journal|June 10, 2010
The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophagesAmanda E Lane, Joanne T M Tan, Clare L Hawkins, et al.
Osteoarthritis and Cartilage|March 15, 2011
OARSI-FDA initiative: defining the disease state of osteoarthritisN E Lane, K Brandt, G Hawker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 1998
Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivoN E Lane, J M Thompson, D Haupt, et al.
The American Journal of Pathology|October 6, 2015
Sphingosine-1-phosphate receptor antagonism enhances proliferation and migration of engrafted neural progenitor cells in a model of viral-induced demyelinationCaroline A Blanc, Jonathan J Grist, Hugh Rosen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 20, 2016
Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention TrialW B Katzman, E Vittinghoff, D M Kado, et al.
The Journal of Clinical Investigation|October 28, 1998
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trialN E Lane, S Sanchez, G W Modin, et al.
Evolution; International Journal of Organic Evolution|May 26, 2017
Multilevel and sex-specific selection on competitive traits in North American red squirrelsDavid N Fisher, Stan Boutin, Ben Dantzer, et al.
Arthritis and Rheumatism|January 30, 2010
Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men studyR K Chaganti, N Parimi, P Cawthon, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 12, 2000
Identification and regional distribution of the dopamine D(1A) receptor in the gastrointestinal tractC J Vaughan, A M Aherne, E Lane, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 10, 2000
Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trialN E Lane, S Sanchez, G W Modin, et al.
Pageof 143